USPTO serial 79255966
BENEVOLENTAI
Reviewed by CopyMark Law Group
Reg. 6026106Status 707Registered
- Filing date
- Status date
- Registration date
- Apr 7, 2020
- Examiner
- DANTZLER, LAUREN ALEXANDRIA
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with BENEVOLENTAI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; medicines for the treatment of diseases affecting the central nervous system; medicines for veterinary purposes in the nature of antibiotics; antibiotics for human use; antibiotics for veterinary use; antibiotic food supplements for animals; chemical reagents for medical use; chemical reagents for veterinary use; central nervous system stimulants; nutritional supplements; nutritional supplements for veterinary use; vitamin and mineral supplements; vitamin supplements for animals; veterinary vaccines ] | SECTION 71 - CANCELLED | — |
| 009 | [ Artificial intelligence apparatus, namely, computer hardware and recorded software for implementing artificial intelligence in products and services; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines | ACTIVE | — |
| 010 | [ Medical instruments for therapeutic drug monitoring; testing apparatus for DNA and RNA testing for medical purposes ] | SECTION 71 - CANCELLED | — |
| 041 | [ Library services provided by means of a computerized database; library services, namely, providing electronic library services featuring data stored and retrieved by electronic means; publication of books; publication of journals; publication of electronic books and journals online; publication of material in the nature of electronic books and journals which can be accessed from databases or from the Internet; publication of the results of clinical trials for pharmaceutical preparations in the field of diseases affecting the central nervous system; publication of the results of clinical trials for pharmaceutical preparations ] | SECTION 71 - CANCELLED | — |
| 042 | [ Design and development of computer software; ] providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of healthcare; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; [ hosting of digital content online; hosting of digital content, namely, online journals; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and development, all of the aforesaid services also provided online via a database or the Internet ] | ACTIVE | — |
| 044 | [ Healthcare information, advisory and consultancy services; medical services; medical information, advisory and consultancy services; medical testing for diagnostic or treatment purposes; consulting services in the fields of pharmaceutical research and development; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consulting and advisory services in the fields of pharmaceutical research and development; veterinary services; veterinary information, advisory and consultancy services; collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals, all of the aforesaid services also provided online via a database or the Internet ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BENEVOLENTAI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Nov 5, 2026 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Nov 2, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 30, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 16, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 16, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 16, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 29, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 12, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 30, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 1, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 1, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 19, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 18, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 18, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 18, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 18, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 10, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 11, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 11, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 21, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 20, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |